Moderna, Inc. (MRNA)
$216.25+1.17%Close
BUYRECOVERY · day 31
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV34.6%–204.8%
- Market cap
- $85.8B
- Beta
- 0.90
- P/E (TTM)
- -27.10
- IV-%ile
- 76
- IV ATM
- 84.8%
- Short % float
- 8.34%
- Days to cover
- 1.8
- SI change
- -6.1%
- 1W
- +15.36%
- 1M
- +47.42%
- vs SPY 1W
- +15.50%
- vs SPY 1M
- +44.91%
Industry peers
FMP comparable companies · ranked by market cap
- PFESELLPfizer Inc.$161.9BBULLQ 13$28.40-0.11%
- GSKSELLGSK plc$94.0BRECOVERYQ 14$46.92-1.39%
- BNTXSELLBioNTech SE$24.1BCRISISQ 35$95.84-7.13%
- PCVXBUYVaxcyte, Inc.$10.2BRECOVERYQ 25$70.65-5.45%
- NVAXBUYNovavax, Inc.$2.1BBULLQ 10$12.66+1.26%
- VIRBUYVir Biotechnology, Inc.$1.9BRECOVERYQ 12$11.30-6.11%
- VALNSELLValneva SE$562MCRISISQ -1$5.93-6.24%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on MRNA?
- LOPJLB’s latest quantitative signal on Moderna, Inc. (MRNA) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is MRNA in?
- Moderna, Inc. (MRNA) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Moderna, Inc. (MRNA) do?
- Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spann…